Skip to content

Cencora COR PP&E (Net)

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$26.54B+43.7%
Cardinal Health logo
Cardinal HealthCAH
$2.93B+9.9%
McKesson logo
McKessonMCK
$2.67B+6.6%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$89.81M+11.6%
AbbVie logo
AbbVieABBV
$5.69B+8.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$444.61M+4.1%

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.06B-0.1%
Enterprise value$65.06B+6.5%
P/E15.3×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's PP&E (net)?
Cencora (COR) reported PP&E (net) of $2.81B in Q1 2026.
How has Cencora's PP&E (net) changed year-over-year?
Cencora's PP&E (net) increased by 21.8% year-over-year, from $2.3B to $2.81B.
What is the long-term trend for Cencora's PP&E (net)?
Over 4 years (2021 to 2025), Cencora's PP&E (net) has grown at a 4.1% compound annual growth rate (CAGR), from $2.16B to $2.54B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.